DPP4 inhibitor

This page covers all DPP4 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting DPP4 (Dipeptidyl peptidase-4), DPP4 (dipeptidyl peptidase-4).

Targets

DPP4 (Dipeptidyl peptidase-4) · DPP4 (dipeptidyl peptidase-4)

Marketed (2)

• Other DPP4-i · Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders · Diabetes
  DPP4 inhibitors block the enzyme dipeptidyl peptidase-4, which prolongs the action of incretin hormones to increase insulin secretion and lower blood glucose in type 2 diabetes.
• DPP4 inhibitor · AstraZeneca · Diabetes
  DPP4 inhibitors block the enzyme dipeptidyl peptidase-4, which prolongs the activity of incretin hormones that stimulate insulin secretion in response to glucose.